The Case for Restraint

Every aesthetic curriculum, including our own, is organised around the affirmative case. Here is the anatomy, here is the product, here is the plane, here is the technique, here is the result. Almost nothing is organised around the negative case: the patient in front of you who would be better served by being told, politely and without drama, that today there is nothing worth doing.

That omission is not accidental. A course that teaches a procedure can demonstrate it. A course that teaches refusal has nothing to photograph. Yet in twenty years of practice and teaching, the single variable that most reliably separates a good injector from a merely competent one is not dexterity, product knowledge or anatomical recall. It is the willingness to do less than the patient asked for, and to be comfortable explaining why.

The first three papers in this series argued that treatment should follow the cells, the plane and the sequence. This paper adds the constraint that makes those three usable: not everything that can be treated should be, and the decision to withhold is itself a clinical act with its own reasoning, its own documentation and its own duty of care.

The central claim of this series is that anatomical ageing is not a treatment target. Bone remodels, fat compartments deflate and descend, ligaments lengthen, skin thins. None of this is pathology. It is the ordinary trajectory of a living face, and it cannot be reversed by anything we inject.

What we can do — and what the evidence supports — is manage the appearance of that trajectory. That distinction sounds semantic until you watch what happens when it is ignored. A practitioner who believes they are reconstructing the younger face will keep adding volume until the arithmetic of the face is wrong: a midface that projects further than it ever did, a jawline wider than the skull that carries it, lips that no longer relate to the teeth behind them. Each individual millilitre was defensible. The sum was not.

Camouflage is the honest description of most of what we do well. A superficial correction that softens the shadow of a hollow is a smaller, safer and more durable act than a deep attempt to rebuild the structure that cast it. Restraint begins with accepting that the smaller act is usually the correct one.

Techniques rarely fail because they are wrong. They fail because they escape their indication. A method is described for a narrow anatomical problem, produces a striking photograph, is taught as a signature, and within two years is being applied to patients who never had the problem it was designed to solve.

The pattern is consistent enough to be predictable. Highly structured lip techniques that redistribute volume vertically were developed for particular lip morphologies and particular tissue qualities; applied indiscriminately they produce a lip that is tense, pale on animation, and dependent on repeat treatment to look intentional. Broad fanning in the subcutaneous plane is efficient for large, even deficits; used as a default it spreads product where there was no deficit and blunts the natural transitions that make a face read as three-dimensional. Aggressive deep-plane volumisation of the midface is genuinely indicated in some patients; used routinely in younger ones it creates the lateral fullness that patients themselves later describe as looking 'done'.

None of these techniques is illegitimate. Each is being cited here as an example of the same failure mode — the migration of a method from indication to habit. The clinical question is never 'is this technique good?' It is 'is this technique good for the anatomy in front of me, today, at this stage?'

First: when the dominant problem is in a domain you are not being asked to treat. A patient requesting more filler for a midface that has adequate support but poor skin quality has a skin problem, not a volume problem. Adding product does not correct the deficit; it makes the skin harder to correct later. The sequencing argument in Part 3 exists precisely to prevent this.

Second: when the request is driven by an image rather than an anatomy. A photograph of another person's face is a request for a different skull. It should be met with an explanation, not with a compromise dose that satisfies nobody.

Third: when the tissue has not recovered. Interval matters more than dose. Repeated treatment before oedema, integration and remodelling have settled produces a cumulative result nobody planned, and it removes the practitioner's ability to judge what the previous treatment actually achieved.

Fourth: when psychological risk outweighs aesthetic gain. Body dysmorphic disorder is materially more prevalent in aesthetic settings than in the general population, and treatment reliably fails to relieve it. Screening, and declining, is the correct clinical response — and the one most likely to be resented at the time and vindicated later.

A decision not to treat should look, in the notes, exactly like a decision to treat: assessed, reasoned, discussed and recorded. Record the domain assessment, the dominant deficit, the reason the requested intervention was not indicated today, the alternative offered, and the review interval. This protects the patient, it protects the practitioner, and it converts restraint from an instinct into a repeatable clinical process.

It also changes the consultation. Patients tolerate 'not today' considerably better than the profession assumes, provided it arrives with a reason and a plan. What they do not tolerate is being sold something and later discovering that a more experienced clinician would have declined.

The commercial objection is obvious and worth naming: refusing treatment costs money in the short term. In practice it is the single most reliable generator of the two things that sustain a clinic over a decade — referral and return. The practitioner known for saying no is the practitioner whose yes carries weight.

Taken together, these four papers describe one position. Treat the cell that is failing, in the plane that owns the problem, in the order that biology dictates, and only as far as the face in front of you will carry.

Technique can be taught in a weekend. Sequencing takes a year. Restraint takes a career, and it is acquired mostly by looking honestly at your own eighteen-month results. The purpose of this series is to shorten that curve slightly — not by adding another method, but by making the decision architecture explicit.